AD
Ayala Pharmaceuticals, Inc.
ADXS · OTC
$0.60 +0.00% (+$0.00)
Market Cap $6.31M
P/E Ratio 0.26x
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
72 /100
Cheap P/E 0.26x
EV/EBITDA 2.96x
P/S 0.09x
Growth
4 /100
Declining Rev. growth 9.81%
Book val. growth 1.03%
EPS growth N/A
Profitability
57 /100
Moderate Gross margin 94.85%
Net margin 17.63%
Op. margin 59.47%
Quality
14 /100
Poor ROIC 33.02%
ROA 4.48%
Asset turnover 0.25x
Debt
45 /100
Moderate Debt/Equity 1.50x
Current ratio 3.91x
Int. coverage 1.26x
Stability
45 /100
Moderate Beta -4.03x
Rev. volatility 10.59%
EPS volatility 6,761.11%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ADXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kenneth A. Berlin
Employees
20
Headquarters
Monmouth Junction